HUNTINGTON KORE OLGUSUNDA BAŞARILI ANESTEZİ YÖNETİMİ VE DERLENMEDE SUGAMMADEKS KULLANIMI-OLGU SUNUMU

Year 2020, Volume: 3 Issue: 2, 74 - 76, 27.06.2020

Şule Özbilgin Meltem Genez

Abstract

Huntington koresi (HK) otozomal dominant geçişli, ilerleyici özellikte bir hastalıktır ve bazal ganglionların ilerleyici şekilde etkilenmesi ile ortaya çıkar. Hastalarda regürjitasyon ve pulmoner aspirasyon riskinde artma, uzamış tiyopental ve süksinilkolin cevabı, solunum güçlüğü, rijit spazma kadar ilerleyebilen postoperatif titreme gibi komplikasyonlarla karşılaşılabilir. Prevalansı 100000 de 4-10 olan bu hastalıkla ilişkili olarak literatürde bildirilen anestezi yöntemleri sınırlı olguda denenmiştir. Olgu sunumumuzda HK hastalığı olan 50 yaşında erkek hastanın anestezi yönetimini sunmayı amaçladık. Antikolinesteraz kullanımından kaçınmak amacıyla 100 mg sugammadeks verilen hasta başarılı bir şekilde ekstübe edildi ve derlenmesi sağlandı.

Keywords

Huntington hastalığı, anestezi yönetimi, sugammadeks

Supporting Institution

yok

SUCCESSFUL ANESTHETIC MANAGEMENT AND RECOVERY WITH SUGAMMADEX IN A PATIENT WITH HUNTINGTON’S CHOREA-A CASE REPORT

Abstract

ABSTRACT
Huntington’s chorea (HC) is an autosomal dominant hereditary disease with progressive characteristics affecting the basal ganglia. Patients may encounter complications like increased risk of regurgitation and pulmonary aspiration, prolonged thiopental and succinylcholine response, respiratory difficulties and postoperative shivering advancing to rigid spasms. With a prevalence of 4-10/100.000, there are limited case reports about anesthetic methods for this disease in the literature. In our case report, we aimed to present the anesthetic management of a 50-year old male patient with HC disease. Avoiding the use of anticholinesterase, 100 mg sugammadex was administered, the patient was successfully extubated and recovery was ensured.

Keywords

Huntington disease, anesthetic management, sugammadex

References

• Tollis D. Who was ... Huntington? Nurs Times. 1995;91(27):45.
• Gilli E, Bartoloni A, Fiocca F, Dall’Antonia F, Carluccio S. Anaesthetic management in a case of Huntington’s chorea. Minerva Anestesiol. 2006;72:757-762.
• Cangemi CF Jr, Miller RJ. Huntington’s disease: review and anesthetic case management. Anesth Prog. 1998;45:150-153.
• Blanloeil Y, Bigot A, Dixneuf B. Anaesthesia in Huntington's chorea. Anaesthesia. 1982;37:695-696. doi:10.1111/j.1365-2044.1982.tb01287.x
• Stoelting RK, Miller RD. Basics of Anesthesia. 3rd Edition. New York: Churchill Livingstone Inc.; 1994.
• Gualandi W, Bonfanti G. A case of prolonged apnea in Huntington's chorea. Acta Anaesthesiol (Padova). 1968:19(suppl 6):235-238.
• Costarino A, Gross JB. Patients with Huntington's chorea may respond normally to succinylcholine. Anesthesiology. 1985;63:570. doi:10.1097/00000542-198511000-00032
• Kang JM, Chung JY, Han JH, et al. Anesthetic management of a patient with Huntington’s chorea- A case report. Korean J Anesthesiol. 2013;64(3):262-264. doi:10.4097/kjae.2013.64.3.262
• Blobner M, Eriksson L, Scholz J, et al. Sugammadex (2 mg/kg) significantly faster reverses shallow rocuronium-induced neuromuscular blockade compared with Neostigmine (50 microgram/kg). Eur J Anaesthesiol. 2007;24(suppl 39):125-126. doi:10.1097/00003643-200706001-00465
• Uluer MS, Sargin M, Ozmen S. High dose Suggammadex administiration in a case of Huntington chorea. Med Science. 2016;5(1):301-305. doi:10.5455/medscience.2015.04.8313